All News

Analyzing copayments and coverage plans for popular weight-loss drugs in the US, researchers addressed the cost-effectiveness of GLP-1 medications for treating obesity.

A discussion with Madison Irwin, PharmD, BCPS, clinical pharmacist specialist in palliative care at University of Michigan Health and clinical assistant professor at the University of Michigan College of Pharmacy.

Three posters showcased at IDWeek 2024 focused on enhancing access to HIV prevention and treatment, as well as increasing uptake of pre-exposure prophylaxis (PrEP) among women.

Opioid use disorder risk was higher in a cohort of patients with chronic pain without disability.

Researchers explored the stigmatization of sexually transmitted infections across film while also identifying inaccuracies in STI-related content on Tik Tok.

Multimodal analgesia provides more effective pain management—and leads to a decrease in opioid use.

Researchers explored the overall efficacy of various pediatric vaccines and their effects on antibiotic use, while also addressing vaccine hesitancy among parents.

Pharmacist education can positively impact patient counseling around vaccinations in older adults.

Suzetrigine could represent the first new nonopioid drug in a distinct class of pain medications in approximately 20 years.

A conversation with Rakesh Jain, MD, MPH, clinical professor in the Department of Psychiatry at Texas Tech University School of Medicine.

In case you missed it, this week we had stories about medication adherence and breast cancer outcomes, new vaccines in the pipeline, independent pharmacies saying no to Medicare drug price, and more.

Check out this recap of articles published on our sister sites during the past week.

Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.

Acupuncture, a practice with thousands of years of history, has become increasingly accepted in mainstream medicine.

Vaccination against HPV can prevent thousands of cases of cancer each year.

Researchers explored the efficacy of Pfizer-BioNTech’s updated COVID-19 vaccine for the 2023-2024 period and its efficacy in improving various patient outcomes.

David Pope, PharmD, Chief Pharmacy Officer at XiFin, joined Drug Topics to discuss value-based care and how it has changed the way pharmacy operates.

Pharmacist management of chronic conditions can lead to improved patient outcomes.

Patients with chronic migraine can frequently overuse acute medications, leading to medication overuse headaches.

Three RSV vaccines are currently FDA approved for use in adults aged 60 or older.

In posters presented at the American College of Clinical Pharmacy 2024 Annual Meeting, researchers explored the implementation of collaborative care programs within various health systems.

Cases of meningococcal disease currently exceed prepandemic levels.

Findings from a collection of posters at ACCP underscore the critical role of community pharmacies in promoting health equity and providing high-quality, patient-centered care.

The National Community Pharmacists Association surveyed over 4000 independent pharmacy owners and managers for their thoughts on the 10 drugs selected for Medicare price negotiations.

James Rider, PharmD, shared his experiences as a pharmacy manager at CVS.

Dozens of presentations at IDWeek 2024 focused on available immunizations, such as those for COVID-19, respiratory syncytial virus, and flu.

David Pope, PharmD, Chief Pharmacy Officer at XiFin, discussed pharmacy benefit managers and their impact on value-based care within pharmacies.

In an installment of Drug Topics’ 5 Questions With a Pharmacist, Stevie Veach of MercyOne Pharmacy in Dubuque, Iowa, talked about her pharmacy’s offerings and how they serve her community’s patients.